Watch Demo

Global Brain Tumor Diagnosis and Treatment Industry

Global Brain Tumor Diagnosis and Treatment Industry

  • Publish Date:October 2022

  • Number of Pages:173

  • Report ID:5960584

  • Format:PDF

  • Publisher:Global Industry Analysts

$ 5450

Summary

Abstract:

What’s New for 2022?

Global competitiveness and key competitor percentage market shares
Market presence across multiple geographies - Strong/Active/Niche/Trivial
Online interactive peer-to-peer collaborative bespoke updates
Access to our digital archives and MarketGlass Research Platform
Complimentary updates for one year

Global Brain Tumor Diagnosis and Treatment Market to Reach $887.5 Million by 2027

In the changed post COVID-19 business landscape, the global market for Brain Tumor Diagnosis and Treatment estimated at US$537.5 Million in the year 2020, is projected to reach a revised size of US$887.5 Million by 2027, growing at a CAGR of 7.4% over the period 2020-2027. Primary Brain Tumor, one of the segments analyzed in the report, is projected to record 7.2% CAGR and reach US$587.1 Million by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Secondary Brain Tumor segment is readjusted to a revised 7.9% CAGR for the next 7-year period.

The U.S. Market is Estimated at $145.3 Million, While China is Forecast to Grow at 11.2% CAGR

The Brain Tumor Diagnosis and Treatment market in the U.S. is estimated at US$145.3 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$197 Million by the year 2027 trailing a CAGR of 11.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 4% and 6.6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.8% CAGR.

Select Competitors (Total 42 Featured) -
AstraZeneca PLC
Carestream Health, Inc.
GE Healthcare
Hitachi Medical Corporation
Merck & Co., Inc.
Pfizer, Inc.
Philips Healthcare
Shimadzu Corporation
Siemens Healthineers
Toshiba Medical Systems Corporation

Table of contents

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Brain Tumor Diagnosis and Treatment - Global Key Competitors
Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for
Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Recent Past, Current & Future Analysis for Brain
Tumor Diagnosis and Treatment by Geographic Region - USA,
Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2020 through 2027 and % CAGR

Table 2: World Historic Review for Brain Tumor Diagnosis and
Treatment by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2012 through 2019 and % CAGR

Table 3: World 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Geographic Region - Percentage Breakdown of
Value Sales for USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets for
Years 2012, 2021 & 2027

Table 4: World Recent Past, Current & Future Analysis for
Primary Brain Tumor by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 5: World Historic Review for Primary Brain Tumor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 6: World 15-Year Perspective for Primary Brain Tumor by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 7: World Recent Past, Current & Future Analysis for
Secondary Brain Tumor by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 8: World Historic Review for Secondary Brain Tumor by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 9: World 15-Year Perspective for Secondary Brain Tumor by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 10: World Recent Past, Current & Future Analysis for CT
Scan by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 11: World Historic Review for CT Scan by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 12: World 15-Year Perspective for CT Scan by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 13: World Recent Past, Current & Future Analysis for MRI
by Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2020 through 2027 and % CAGR

Table 14: World Historic Review for MRI by Geographic Region -
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 15: World 15-Year Perspective for MRI by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 16: World Recent Past, Current & Future Analysis for
PET-CT Scan by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 17: World Historic Review for PET-CT Scan by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 18: World 15-Year Perspective for PET-CT Scan by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 19: World Recent Past, Current & Future Analysis for
Other Diagnosis Types by Geographic Region - USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets - Independent Analysis of Annual Sales in
US$ Thousand for Years 2020 through 2027 and % CAGR

Table 20: World Historic Review for Other Diagnosis Types by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 21: World 15-Year Perspective for Other Diagnosis Types
by Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 22: World Recent Past, Current & Future Analysis for
Surgery by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 23: World Historic Review for Surgery by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 24: World 15-Year Perspective for Surgery by Geographic
Region - Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2021 & 2027

Table 25: World Recent Past, Current & Future Analysis for
Radiation Therapy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 26: World Historic Review for Radiation Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 27: World 15-Year Perspective for Radiation Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 28: World Recent Past, Current & Future Analysis for
Targeted Therapy by Geographic Region - USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2020 through 2027 and % CAGR

Table 29: World Historic Review for Targeted Therapy by
Geographic Region - USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 30: World 15-Year Perspective for Targeted Therapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 31: World Recent Past, Current & Future Analysis for
Chemotherapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 32: World Historic Review for Chemotherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 33: World 15-Year Perspective for Chemotherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 34: World Recent Past, Current & Future Analysis for
Immunotherapy by Geographic Region - USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 35: World Historic Review for Immunotherapy by Geographic
Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 36: World 15-Year Perspective for Immunotherapy by
Geographic Region - Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2021 & 2027

Table 37: World Brain Tumor Diagnosis and Treatment Market
Analysis of Annual Sales in US$ Thousand for Years 2012 through
2027

III. MARKET ANALYSIS

UNITED STATES
Brain Tumor Diagnosis and Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United States
for 2022 (E)
Table 38: USA Recent Past, Current & Future Analysis for Brain
Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 39: USA Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 40: USA 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 41: USA Recent Past, Current & Future Analysis for Brain
Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 42: USA Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 43: USA 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2021 & 2027

Table 44: USA Recent Past, Current & Future Analysis for Brain
Tumor Diagnosis and Treatment by Treatment Type - Surgery,
Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 45: USA Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 46: USA 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2021 & 2027

CANADA
Table 47: Canada Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Type - Primary Brain
Tumor and Secondary Brain Tumor - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 48: Canada Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 49: Canada 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 50: Canada Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT
Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 51: Canada Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 52: Canada 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2021 & 2027

Table 53: Canada Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Treatment Type -
Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 54: Canada Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 55: Canada 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2021 & 2027

JAPAN
Brain Tumor Diagnosis and Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Japan for 2022 (E)
Table 56: Japan Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Type - Primary Brain
Tumor and Secondary Brain Tumor - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 57: Japan Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 58: Japan 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 59: Japan Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT
Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 60: Japan Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 61: Japan 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2021 & 2027

Table 62: Japan Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Treatment Type -
Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 63: Japan Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 64: Japan 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2021 & 2027

CHINA
Brain Tumor Diagnosis and Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in China for 2022 (E)
Table 65: China Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Type - Primary Brain
Tumor and Secondary Brain Tumor - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 66: China Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 67: China 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 68: China Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT
Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 69: China Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 70: China 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2021 & 2027

Table 71: China Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Treatment Type -
Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 72: China Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 73: China 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2021 & 2027

EUROPE
Brain Tumor Diagnosis and Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Europe for 2022 (E)
Table 74: Europe Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Geographic Region -
France, Germany, Italy, UK, Spain, Russia and Rest of Europe
Markets - Independent Analysis of Annual Sales in US$ Thousand
for Years 2020 through 2027 and % CAGR

Table 75: Europe Historic Review for Brain Tumor Diagnosis and
Treatment by Geographic Region - France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets - Independent Analysis
of Annual Sales in US$ Thousand for Years 2012 through 2019 and
% CAGR

Table 76: Europe 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Geographic Region - Percentage Breakdown of
Value Sales for France, Germany, Italy, UK, Spain, Russia and
Rest of Europe Markets for Years 2012, 2021 & 2027

Table 77: Europe Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Type - Primary Brain
Tumor and Secondary Brain Tumor - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 78: Europe Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 79: Europe 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 80: Europe Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT
Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 81: Europe Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 82: Europe 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2021 & 2027

Table 83: Europe Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Treatment Type -
Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 84: Europe Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 85: Europe 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2021 & 2027

FRANCE
Brain Tumor Diagnosis and Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in France for 2022 (E)
Table 86: France Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Type - Primary Brain
Tumor and Secondary Brain Tumor - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 87: France Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 88: France 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 89: France Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT
Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 90: France Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 91: France 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2021 & 2027

Table 92: France Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Treatment Type -
Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 93: France Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 94: France 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2021 & 2027

GERMANY
Brain Tumor Diagnosis and Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in Germany for 2022 (E)
Table 95: Germany Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Type - Primary Brain
Tumor and Secondary Brain Tumor - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 96: Germany Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 97: Germany 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 98: Germany Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT
Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 99: Germany Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 100: Germany 15-Year Perspective for Brain Tumor
Diagnosis and Treatment by Diagnosis Type - Percentage
Breakdown of Value Sales for CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types for the Years 2012, 2021 & 2027

Table 101: Germany Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Treatment Type -
Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 102: Germany Historic Review for Brain Tumor Diagnosis
and Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 103: Germany 15-Year Perspective for Brain Tumor
Diagnosis and Treatment by Treatment Type - Percentage
Breakdown of Value Sales for Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy for the Years
2012, 2021 & 2027

ITALY
Table 104: Italy Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Type - Primary Brain
Tumor and Secondary Brain Tumor - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 105: Italy Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 106: Italy 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 107: Italy Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Diagnosis Type - CT
Scan, MRI, PET-CT Scan and Other Diagnosis Types - Independent
Analysis of Annual Sales in US$ Thousand for the Years 2020
through 2027 and % CAGR

Table 108: Italy Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 109: Italy 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2021 & 2027

Table 110: Italy Recent Past, Current & Future Analysis for
Brain Tumor Diagnosis and Treatment by Treatment Type -
Surgery, Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 111: Italy Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -
Independent Analysis of Annual Sales in US$ Thousand for Years
2012 through 2019 and % CAGR

Table 112: Italy 15-Year Perspective for Brain Tumor Diagnosis
and Treatment by Treatment Type - Percentage Breakdown of Value
Sales for Surgery, Radiation Therapy, Targeted Therapy,
Chemotherapy and Immunotherapy for the Years 2012, 2021 & 2027

UNITED KINGDOM
Brain Tumor Diagnosis and Treatment Market Presence - Strong/
Active/Niche/Trivial - Key Competitors in the United Kingdom
for 2022 (E)
Table 113: UK Recent Past, Current & Future Analysis for Brain
Tumor Diagnosis and Treatment by Type - Primary Brain Tumor and
Secondary Brain Tumor - Independent Analysis of Annual Sales in
US$ Thousand for the Years 2020 through 2027 and % CAGR

Table 114: UK Historic Review for Brain Tumor Diagnosis and
Treatment by Type - Primary Brain Tumor and Secondary Brain
Tumor Markets - Independent Analysis of Annual Sales in US$
Thousand for Years 2012 through 2019 and % CAGR

Table 115: UK 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Type - Percentage Breakdown of Value Sales for
Primary Brain Tumor and Secondary Brain Tumor for the Years
2012, 2021 & 2027

Table 116: UK Recent Past, Current & Future Analysis for Brain
Tumor Diagnosis and Treatment by Diagnosis Type - CT Scan, MRI,
PET-CT Scan and Other Diagnosis Types - Independent Analysis of
Annual Sales in US$ Thousand for the Years 2020 through 2027
and % CAGR

Table 117: UK Historic Review for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - CT Scan, MRI, PET-CT Scan and
Other Diagnosis Types Markets - Independent Analysis of Annual
Sales in US$ Thousand for Years 2012 through 2019 and % CAGR

Table 118: UK 15-Year Perspective for Brain Tumor Diagnosis and
Treatment by Diagnosis Type - Percentage Breakdown of Value
Sales for CT Scan, MRI, PET-CT Scan and Other Diagnosis Types
for the Years 2012, 2021 & 2027

Table 119: UK Recent Past, Current & Future Analysis for Brain
Tumor Diagnosis and Treatment by Treatment Type - Surgery,
Radiation Therapy, Targeted Therapy, Chemotherapy and
Immunotherapy - Independent Analysis of Annual Sales in US$
Thousand for the Years 2020 through 2027 and % CAGR

Table 120: UK Historic Review for Brain Tumor Diagnosis and
Treatment by Treatment Type - Surgery, Radiation Therapy,
Targeted Therapy, Chemotherapy and Immunotherapy Markets -

Please contact our Customer Support Center to get the complete Table of Contents

Methodology

Our market research methodology is designed to provide the clients with comprehensive and accurate information on various industries and markets. It includes data collection, primary interviews, macro-economic factor analysis, country-level data analysis etc.

The data is gathered from a wide range of sources, including industry reports, government statistics, and company financials. This data is then analyzed and cross-referenced to ensure its accuracy and reliability. Next, primary interviews are conducted with industry experts and key stakeholders to gather their insights and perspectives on the market. This information is then combined with the data collected to provide a complete picture of the market. Macro-economic factor analysis is also carried out to understand the impact of external factors on the market. Finally, country-level data analysis is performed to understand the market dynamics in specific regions and countries.

Reportlinker's market research methodology is designed to provide clients with a clear understanding of the market, its trends, and its future potential.